Actas Dermo-Sifiliográficas (Apr 2023)
Anti-Interleukin 23 Biologic Are Mostly Effective and Safe in Psoriatic Patients Who Failed Anti-Interleukin 17. A Real-Life, Retrospective 52-Week Experience
Abstract
No abstracts available.
Actas Dermo-Sifiliográficas (Apr 2023)